Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2011

Open Access 01-12-2011 | Research

Prognostic factors in patients with node-negative gastric cancer: an Indian experience

Authors: Ramakrishnan A Seshadri, Sunil B Jayanand, Rama Ranganathan

Published in: World Journal of Surgical Oncology | Issue 1/2011

Login to get access

Abstract

Background

The status of the regional nodes is the most important prognostic factor in gastric cancer. There are subgroups of patients with different prognosis even in node-negative patients of gastric cancer. The aim of this study is to analyze the factors influencing the prognosis in Indian patients with node-negative gastric cancer.

Methods

This was a retrospective analysis of patients who underwent radical gastrectomy in a tertiary cancer centre in India between1991 and 2007. The study group included only patients with histologically node-negative disease. Various clinical, pathological and treatment related factors in this group of patients were analyzed to determine their prognostic ability by univariate and multivariate analyses.

Results

Among the 417 patients who underwent gastrectomy during this period, 122 patients had node-negative disease. A major proportion of the patients had advanced gastric cancer. The 5-year overall survival and disease-free survival in all node-negative gastric cancer patients was 68.2% and 67.5% respectively. The overall recurrence rate in this group was 27.3%. On univariate analysis, the factors found to significantly influence the disease-free survival were the size, location and presence or absence of serosal invasion of the primary tumor. However, on multivariate analysis, only tumor size more than 3 cm and serosal invasion were found to be independently associated with an inferior survival.

Conclusion

Serosal invasion and primary tumor size more than 3 cm independently predict a poor outcome in patients with node-negative gastric cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siewert JR, Bottcher K, Stein HJ, Roder JD: Relevant prognostic facors in gastric cancer: Ten year results of the German Gastric Cancer Study. Ann Surg. 1998, 228: 449-461. 10.1097/00000658-199810000-00002.PubMedCentralCrossRefPubMed Siewert JR, Bottcher K, Stein HJ, Roder JD: Relevant prognostic facors in gastric cancer: Ten year results of the German Gastric Cancer Study. Ann Surg. 1998, 228: 449-461. 10.1097/00000658-199810000-00002.PubMedCentralCrossRefPubMed
2.
go back to reference Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer. 1998, 1: 125-133. 10.1007/s101200050006.CrossRefPubMed Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer. 1998, 1: 125-133. 10.1007/s101200050006.CrossRefPubMed
3.
go back to reference Lee CC, Wu CW, Lo SS, Chen JH, Li AF, Hsieh MC, Shen KH, Lui WY: Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol. 2007, 22: 1014-1018. 10.1111/j.1440-1746.2006.04488.x.CrossRefPubMed Lee CC, Wu CW, Lo SS, Chen JH, Li AF, Hsieh MC, Shen KH, Lui WY: Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol. 2007, 22: 1014-1018. 10.1111/j.1440-1746.2006.04488.x.CrossRefPubMed
4.
go back to reference Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, Bechi P, Cortesini C: Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol. 2000, 74: 30-32. 10.1002/1096-9098(200005)74:1<30::AID-JSO7>3.0.CO;2-2.CrossRefPubMed Bruno L, Nesi G, Montinaro F, Carassale G, Boddi V, Bechi P, Cortesini C: Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol. 2000, 74: 30-32. 10.1002/1096-9098(200005)74:1<30::AID-JSO7>3.0.CO;2-2.CrossRefPubMed
5.
go back to reference Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H: Significant prognostic factors in patients with node-negative gastric cancer. Int Surg. 1999, 84: 331-336.PubMed Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H: Significant prognostic factors in patients with node-negative gastric cancer. Int Surg. 1999, 84: 331-336.PubMed
6.
go back to reference Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K: Surgical treatment and outcome for node-negative gastric cancer. Surgery. 1997, 121: 633-639. 10.1016/S0039-6060(97)90051-9.CrossRefPubMed Maehara Y, Tomoda M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K: Surgical treatment and outcome for node-negative gastric cancer. Surgery. 1997, 121: 633-639. 10.1016/S0039-6060(97)90051-9.CrossRefPubMed
7.
go back to reference Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ, Lu HS: Prognostic impact of dissected lymph node counts on patients with node-negative gastric cancer. World J Gastroenterol. 2009, 15: 3926-3930. 10.3748/wjg.15.3926.PubMedCentralCrossRefPubMed Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ, Lu HS: Prognostic impact of dissected lymph node counts on patients with node-negative gastric cancer. World J Gastroenterol. 2009, 15: 3926-3930. 10.3748/wjg.15.3926.PubMedCentralCrossRefPubMed
8.
go back to reference Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X: Prognosis of gastric cancer patients with node-negative metastasis following curative resection: Outcomes of the survival and recurrence. Can J Gastroenterol. 2008, 22: 835-839.PubMedCentralPubMed Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X: Prognosis of gastric cancer patients with node-negative metastasis following curative resection: Outcomes of the survival and recurrence. Can J Gastroenterol. 2008, 22: 835-839.PubMedCentralPubMed
9.
go back to reference Harrison LE, Karpeh MS, Brennan MF: Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg. 1998, 2: 126-131. 10.1016/S1091-255X(98)80002-4.CrossRefPubMed Harrison LE, Karpeh MS, Brennan MF: Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg. 1998, 2: 126-131. 10.1016/S1091-255X(98)80002-4.CrossRefPubMed
10.
go back to reference Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M: Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol. 2010, 101: 622-625. 10.1002/jso.21562.CrossRefPubMed Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M: Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol. 2010, 101: 622-625. 10.1002/jso.21562.CrossRefPubMed
11.
go back to reference Adachi Y, Mori M, Maehara Y, Kitano S, Sugimachi K: Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg. 1997, 184: 373-377.PubMed Adachi Y, Mori M, Maehara Y, Kitano S, Sugimachi K: Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg. 1997, 184: 373-377.PubMed
12.
go back to reference Huang KH, Chen JH, Wu CW, Lo SS, Hsieh MC, Li AF, Lui WY: Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol. 2009, 24: 1522-1526. 10.1111/j.1440-1746.2009.05844.x.CrossRefPubMed Huang KH, Chen JH, Wu CW, Lo SS, Hsieh MC, Li AF, Lui WY: Factors affecting recurrence in node-negative advanced gastric cancer. J Gastroenterol Hepatol. 2009, 24: 1522-1526. 10.1111/j.1440-1746.2009.05844.x.CrossRefPubMed
13.
go back to reference Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, Kim YJ, Kim SK: Prognostic factors in patients with node-negative gastric carcinoma: A comparison with node-positive gastric carcinoma. World J Gastroenterol. 2006, 12: 1182-1186.PubMedCentralPubMed Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, Kim YJ, Kim SK: Prognostic factors in patients with node-negative gastric carcinoma: A comparison with node-positive gastric carcinoma. World J Gastroenterol. 2006, 12: 1182-1186.PubMedCentralPubMed
14.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, (Eds): Cancer Incidence in five continents Volume IX. IARC scientific publication No.160. 2007, Lyon, France: IARC Press Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, (Eds): Cancer Incidence in five continents Volume IX. IARC scientific publication No.160. 2007, Lyon, France: IARC Press
15.
go back to reference Sobin LH, Wittekind Ch, (Eds): International Union Against Cancer (UICC): TNM Classification of malignant tumours. 2002, Wiley: New York, 6 Sobin LH, Wittekind Ch, (Eds): International Union Against Cancer (UICC): TNM Classification of malignant tumours. 2002, Wiley: New York, 6
16.
go back to reference Qui MZ, Wang ZQ, Zhang DS, Zhou ZW, Li YH, Jiang WQ, Xu RH: Prognostic analysis in node-negative gastric cancer patients in China. Tumor Biol. 2010, Qui MZ, Wang ZQ, Zhang DS, Zhou ZW, Li YH, Jiang WQ, Xu RH: Prognostic analysis in node-negative gastric cancer patients in China. Tumor Biol. 2010,
17.
go back to reference Park SS, Park JM, Kim JH, Kim WB, Lee J, Kim SJ, Kim CS, Mok YJ: Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?. J Surg Oncol. 2006, 94: 16-20. 10.1002/jso.20560.CrossRefPubMed Park SS, Park JM, Kim JH, Kim WB, Lee J, Kim SJ, Kim CS, Mok YJ: Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?. J Surg Oncol. 2006, 94: 16-20. 10.1002/jso.20560.CrossRefPubMed
18.
go back to reference Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E: Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol. 2009, 100: 111-114. 10.1002/jso.21311.CrossRefPubMed Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E: Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol. 2009, 100: 111-114. 10.1002/jso.21311.CrossRefPubMed
19.
go back to reference Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, Rosa F, Marchet A, Coniglio A, Saragoni L, Veltri M, PAcelli F, Roviello F, Nitti D, Giulini SM, De Manzoni G: A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010, 252: 70-73. 10.1097/SLA.0b013e3181e4585e.CrossRefPubMed Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, Rosa F, Marchet A, Coniglio A, Saragoni L, Veltri M, PAcelli F, Roviello F, Nitti D, Giulini SM, De Manzoni G: A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010, 252: 70-73. 10.1097/SLA.0b013e3181e4585e.CrossRefPubMed
20.
go back to reference Lee JH, Choi SH, Min JS, Noh SH: Prognostic impact of lymphatic and/or blood vessel invasion in patients with node negative advanced gastric cancer. Ann Surg Oncol. 2002, 9: 562-567. 10.1007/BF02573892.CrossRefPubMed Lee JH, Choi SH, Min JS, Noh SH: Prognostic impact of lymphatic and/or blood vessel invasion in patients with node negative advanced gastric cancer. Ann Surg Oncol. 2002, 9: 562-567. 10.1007/BF02573892.CrossRefPubMed
21.
go back to reference Baba H, Maehara Y, Takeuchi H, Inutsuka S, Akazawa K, Sugimachi K: Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995, 117: 165-169. 10.1016/S0039-6060(05)80080-7.CrossRefPubMed Baba H, Maehara Y, Takeuchi H, Inutsuka S, Akazawa K, Sugimachi K: Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995, 117: 165-169. 10.1016/S0039-6060(05)80080-7.CrossRefPubMed
22.
go back to reference Kooby DA, Suriawinata A, Klimstra DA, Brennan MF, Karpeh MS: Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003, 237: 828-837.PubMedCentralPubMed Kooby DA, Suriawinata A, Klimstra DA, Brennan MF, Karpeh MS: Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003, 237: 828-837.PubMedCentralPubMed
23.
go back to reference Cascinu S, Graziano F, Catalano V, Valentini M, Rossi MC, Baldelli AM, Ghiselli R, Saba V, Giordani P, Catalano G: Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy. Anticancer Res. 2000, 20: 3839-3842.PubMed Cascinu S, Graziano F, Catalano V, Valentini M, Rossi MC, Baldelli AM, Ghiselli R, Saba V, Giordani P, Catalano G: Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy. Anticancer Res. 2000, 20: 3839-3842.PubMed
24.
go back to reference Maehara Y, Kabashima A, Tokunaga E, Hasuda S, Oki E, Kakeji Y, Baba H, Sugimachi K: Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer. Oncology. 1999, 56: 322-327. 10.1159/000011986.CrossRefPubMed Maehara Y, Kabashima A, Tokunaga E, Hasuda S, Oki E, Kakeji Y, Baba H, Sugimachi K: Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer. Oncology. 1999, 56: 322-327. 10.1159/000011986.CrossRefPubMed
25.
go back to reference Otsuji E, Kuriu Y, Ichikawa D, Ochiai T, Okamoto K, Hagiwara A, Yamagishi H: Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology. 2008, 55: 755-759.PubMed Otsuji E, Kuriu Y, Ichikawa D, Ochiai T, Okamoto K, Hagiwara A, Yamagishi H: Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology. 2008, 55: 755-759.PubMed
26.
go back to reference Giuliani A, Caporale A, Corona M, Di Bari M, Demoro M, Ricciardulli T, Gozzo P, Galati G, Tocchi A: Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count. J Exp Clin Cancer Res. 2004, 23: 215-224.PubMed Giuliani A, Caporale A, Corona M, Di Bari M, Demoro M, Ricciardulli T, Gozzo P, Galati G, Tocchi A: Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count. J Exp Clin Cancer Res. 2004, 23: 215-224.PubMed
27.
go back to reference Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, LealGhezzi T, Rotmensz N, Bagnardi V, Andreoni B: Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011, 37: 305-11.CrossRefPubMed Biffi R, Botteri E, Cenciarelli S, Luca F, Pozzi S, Valvo M, Sonzogni A, Chiappa A, LealGhezzi T, Rotmensz N, Bagnardi V, Andreoni B: Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011, 37: 305-11.CrossRefPubMed
28.
go back to reference Shen JY, Kim S, Cheong JH, Kim YI, Hyung WJ, Choi WH, Choi SH, Wang LB, Noh SH: The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer. 2007, 110: 745-751. 10.1002/cncr.22837.CrossRefPubMed Shen JY, Kim S, Cheong JH, Kim YI, Hyung WJ, Choi WH, Choi SH, Wang LB, Noh SH: The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer. 2007, 110: 745-751. 10.1002/cncr.22837.CrossRefPubMed
29.
go back to reference Wu ZY, Li JH, Zhan WH, He YL, Wan J: Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol. 2007, 13: 4122-4125.PubMedCentralCrossRefPubMed Wu ZY, Li JH, Zhan WH, He YL, Wan J: Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol. 2007, 13: 4122-4125.PubMedCentralCrossRefPubMed
30.
go back to reference Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH: Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 2009, 35: 409-414.CrossRefPubMed Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH: Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 2009, 35: 409-414.CrossRefPubMed
31.
go back to reference Cao L, Hu X, Zhang Y, Huang G: Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol. 2011, 103: 53-56. 10.1002/jso.21755.CrossRefPubMed Cao L, Hu X, Zhang Y, Huang G: Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol. 2011, 103: 53-56. 10.1002/jso.21755.CrossRefPubMed
32.
go back to reference Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S: Prognostic effect of lymphnode micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002, 9: 771-774. 10.1007/BF02574499.CrossRefPubMed Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S: Prognostic effect of lymphnode micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol. 2002, 9: 771-774. 10.1007/BF02574499.CrossRefPubMed
33.
go back to reference Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS: Prognostic relevance of immunohistochemically detected lymphnode micrometastasis in patients with gastric carcinoma. Cancer. 2002, 94: 2867-2873. 10.1002/cncr.10562.CrossRefPubMed Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS: Prognostic relevance of immunohistochemically detected lymphnode micrometastasis in patients with gastric carcinoma. Cancer. 2002, 94: 2867-2873. 10.1002/cncr.10562.CrossRefPubMed
34.
go back to reference Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, Kim CS, Chae YS, Bae JW: The significance of lymphnode micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol. 2008, 97: 125-130. 10.1002/jso.20937.CrossRefPubMed Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, Kim CS, Chae YS, Bae JW: The significance of lymphnode micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol. 2008, 97: 125-130. 10.1002/jso.20937.CrossRefPubMed
35.
go back to reference Cai J, Ikeguchi M, Tsujitani S, Maeta M, Liu J, Kaibara N: Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer. 2001, 4: 66-74. 10.1007/PL00011726.CrossRefPubMed Cai J, Ikeguchi M, Tsujitani S, Maeta M, Liu J, Kaibara N: Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer. 2001, 4: 66-74. 10.1007/PL00011726.CrossRefPubMed
36.
go back to reference Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, for the ACTS-GC group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Eng J Med. 2007, 357: 1810-1820. 10.1056/NEJMoa072252.CrossRef Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, for the ACTS-GC group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Eng J Med. 2007, 357: 1810-1820. 10.1056/NEJMoa072252.CrossRef
37.
go back to reference Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M, GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010, 303: 1729-1737.CrossRefPubMed Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M, GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010, 303: 1729-1737.CrossRefPubMed
Metadata
Title
Prognostic factors in patients with node-negative gastric cancer: an Indian experience
Authors
Ramakrishnan A Seshadri
Sunil B Jayanand
Rama Ranganathan
Publication date
01-12-2011
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2011
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-9-48

Other articles of this Issue 1/2011

World Journal of Surgical Oncology 1/2011 Go to the issue